Post-authorisation Safety Study of Rimegepant in Patients with Migraine and History of Cardiovascular Disease in European Countries

24/03/2023
05/12/2025
EU PAS number:
EUPAS103990
Study
Planned

ENCePP Code of conduct

No
Data sources

Data source(s)

Data sources (types)

Administrative healthcare records (e.g., claims)
Drug prescriptions
Electronic healthcare records (EHR)
Pharmacy dispensing records
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No